LOADING
Comparing AbbVie Inc (ABBV) and Salesforce Inc (CRM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | CRM |
|---|---|---|
| Price | $219.68 | $192.83 |
| Change Today | -2.52% | -3.24% |
| Market Cap | $388.4B | $180.7B |
| P/E Ratio | 92.7 | 24.7 |
| Forward P/E | 15.1 | 14.7 |
| PEG Ratio | 0.52 | 0.91 |
| EPS | $2.37 | $7.81 |
| Revenue Growth (YoY) | 10.0% | 12.1% |
| Profit Margin | 6.9% | 18.0% |
| Return on Equity | 62.3% | 12.4% |
| Dividend Yield | 2.95% | 0.84% |
| Beta | 0.33 | 1.31 |
| 52-Week High | $241.12 | $294.59 |
| 52-Week Low | $159.05 | $174.57 |
| Volume | 5.7M | 14.8M |
AbbVie Inc is the larger company by market capitalization. Salesforce Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Salesforce Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.